Over the past three months, Genesis Healthcare Inc. [GEN] ended the trading day at $0.60 and exhibited a change of 14.26% with a 24 hour trading and reached upto the volume of 923.27K compared to its recorded trading volume of 8.09 million. GEN generated a 1 year amount change with -60.11%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -0.34% with an amount shift of -15.93% over the last month.

On 13, October 2020, LTC ACO Receives Positive Reconciliation and Settlement Under the Medicare Shared Savings Program (MSSP). According to news published on Yahoo Finance, LTC ACO, the first long-term care sponsored Accountable Care Organization (“ACO”) in the United States and a subsidiary of Genesis HealthCare (Genesis) (NYSE:GEN), recently received a positive reconciliation and settlement under the Medicare Shared Savings Program (“MSSP”) for the 2019 performance year and as a result, generated shared savings for the second consecutive year.

Analyst Birdseye View:

The most recent analyst activity for Genesis Healthcare Inc. [NYSE:GEN] stock was on November 21, 2016, when it was Downgrade with a Sector perform rating from RBC Capital Mkts, which also raised its 12-month price target on the stock from $3 to $3.50. On May 16, 2016, RBC Capital Mkts Reiterated an Outperform rating and plunged its price target on this stock from $5 to $3. On May 16, 2016, BofA/Merrill Downgrade an Underperform rating. On January 26, 2016, RBC Capital Mkts Reiterated an Outperform rating and decreased its price target to $5. On January 25, 2016, BofA/Merrill Downgrade a Neutral rating. On November 09, 2015, UBS Reiterated a Neutral rating and decreased its target amount on this stock from $7 to $5.50. On August 10, 2015 RBC Capital Mkts Upgrade an Outperform rating and elevated its amount target to $10.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.50 and a peak of $1.86. Right now, according to Wall Street analyst the average 12-month amount target is $0.75. At the most recent market close, shares of Genesis Healthcare Inc. [NYSE:GEN] were valued at $0.60.

FUNDAMENTAL ANALYSIS

Genesis Healthcare Inc. [NYSE:GEN] most recently reported quarterly sales of 956.0 million, which represented growth of -16.50%. This publicly-traded organization’s revenue is $83,015 per employee, while its income is $266 per employee.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 120.47 and the whole liability to whole assets at 88.70. It shows enduring liability to the whole principal at 112.24 and enduring liability to assets at 0.83 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.5017 points at 1st support level, the second support level is making up to 0.4808. But as of 1st resistance point, this stock is sitting at 0.5417 and at 0.5608 for 2nd resistance point.

Genesis Healthcare Inc. [GEN] reported its earnings at -$0.2 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.03/share signifying the difference of -0.17 and -566.70% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $0.24 calling estimates for -$0.02/share with the difference of 0.26 depicting the surprise of 1,300.00%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Genesis Healthcare Inc. [NYSE:GEN] is 0.90. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.10. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.06 and showing 2.97 of P/E (TTM) ratio.

Insider Stories

The most recent insider trade was by DiVittorio Thomas, EVP and CFO, and it was the sale of 6671.0 shares on Jun 03. Reifsnyder JoAnne Susan, the EVP and Chief Nursing Officer, completed a sale of 5313.0 shares on Jun 03. On Jun 03, Young Stephen Scott, SVP and Treasurer, completed a sale of 3315.0 shares.